These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The significance of transferrin receptors in oncology: the development of functional nano-based drug delivery systems. Tortorella S; Karagiannis TC Curr Drug Deliv; 2014; 11(4):427-43. PubMed ID: 24387131 [TBL] [Abstract][Full Text] [Related]
6. Design and evaluation of injectable niclosamide nanocrystals prepared by wet media milling technique. Ye Y; Zhang X; Zhang T; Wang H; Wu B Drug Dev Ind Pharm; 2015; 41(9):1416-24. PubMed ID: 25204767 [TBL] [Abstract][Full Text] [Related]
7. Controlled delivery of bPEI-niclosamide complexes by PEO nanofibers and evaluation of its anti-neoplastic potentials. Kumar SU; Gopinath P Colloids Surf B Biointerfaces; 2015 Jul; 131():170-81. PubMed ID: 25988281 [TBL] [Abstract][Full Text] [Related]
8. Preparation and in vitro antitumor effects on MDA-MB-231 cells of niclosamide nanocrystals stabilized by poloxamer188 and PBS. Fu Q; Jin X; Zhang Z; Lv H Int J Pharm; 2020 Jun; 584():119432. PubMed ID: 32442644 [TBL] [Abstract][Full Text] [Related]
9. Existing drugs and their application in drug discovery targeting cancer stem cells. Lv J; Shim JS Arch Pharm Res; 2015 Sep; 38(9):1617-26. PubMed ID: 26152874 [TBL] [Abstract][Full Text] [Related]
10. Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer. Sack U; Walther W; Scudiero D; Selby M; Kobelt D; Lemm M; Fichtner I; Schlag PM; Shoemaker RH; Stein U J Natl Cancer Inst; 2011 Jul; 103(13):1018-36. PubMed ID: 21685359 [TBL] [Abstract][Full Text] [Related]
11. Niclosamide, a Drug with Many (Re)purposes. Kadri H; Lambourne OA; Mehellou Y ChemMedChem; 2018 Jun; 13(11):1088-1091. PubMed ID: 29603892 [TBL] [Abstract][Full Text] [Related]
12. Nanoliposomal Encapsulation Enhances Hatamipour M; Jaafari MR; Momtazi-Borojeni AA; Ramezani M; Sahebkar A Anticancer Agents Med Chem; 2019; 19(13):1618-1626. PubMed ID: 31284876 [TBL] [Abstract][Full Text] [Related]
13. Nanostructured Systems in Advanced Drug Targeting for the Cancer Treatment: Recent Patents. Anaya-Ruiz M; Bandala C; Landeta G; Martínez-Morales P; Zumaquero-Rios JL; Sarracent-Pérez J; Pérez-Santos M Recent Pat Anticancer Drug Discov; 2019; 14(1):85-94. PubMed ID: 30381087 [TBL] [Abstract][Full Text] [Related]
14. An update on applications of nanostructured drug delivery systems in cancer therapy: a review. Aberoumandi SM; Mohammadhosseini M; Abasi E; Saghati S; Nikzamir N; Akbarzadeh A; Panahi Y; Davaran S Artif Cells Nanomed Biotechnol; 2017 Sep; 45(6):1-11. PubMed ID: 27632797 [TBL] [Abstract][Full Text] [Related]
15. Tailoring of physicochemical properties of nanocarriers for effective anti-cancer applications. Chakraborty S; Dhakshinamurthy GS; Misra SK J Biomed Mater Res A; 2017 Oct; 105(10):2906-2928. PubMed ID: 28643475 [TBL] [Abstract][Full Text] [Related]
16. The role of nanoparticles in the improvement of systemic anticancer drug delivery. Field LD; Nag OK; Sangtani A; Burns KE; Delehanty JB Ther Deliv; 2018 Jul; 9(7):527-545. PubMed ID: 29943689 [TBL] [Abstract][Full Text] [Related]
17. In Silico Oncology Drug Repositioning and Polypharmacology. Cheng F Methods Mol Biol; 2019; 1878():243-261. PubMed ID: 30378081 [TBL] [Abstract][Full Text] [Related]
18. Combination of niclosamide and current therapies to overcome resistance for cancer: New frontiers for an old drug. Ren J; Wang B; Wu Q; Wang G Biomed Pharmacother; 2022 Nov; 155():113789. PubMed ID: 36271567 [TBL] [Abstract][Full Text] [Related]
19. Nanostructured Systems for the Organelle-specific Delivery of Anticancer Drugs. Joanitti GA; Ganassin R; Rodrigues MC; Figueiro Longo JP; Jiang CS; Gu J; Leal Pinto SM; Almeida Dos Santos MF; de Azevedo RB; Muehlmann LA Mini Rev Med Chem; 2017; 17(3):224-236. PubMed ID: 27739361 [TBL] [Abstract][Full Text] [Related]
20. Computational drugs repositioning identifies inhibitors of oncogenic PI3K/AKT/P70S6K-dependent pathways among FDA-approved compounds. Carrella D; Manni I; Tumaini B; Dattilo R; Papaccio F; Mutarelli M; Sirci F; Amoreo CA; Mottolese M; Iezzi M; Ciolli L; Aria V; Bosotti R; Isacchi A; Loreni F; Bardelli A; Avvedimento VE; di Bernardo D; Cardone L Oncotarget; 2016 Sep; 7(37):58743-58758. PubMed ID: 27542212 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]